ACTA2 and acute myeloid leukemia: Analysis of AML markers revealed the widespread and abundant presence of human cells expressing either ACTA2 or PMEL in the TSC2−/− xenografts, but not in TSC2+/− or TSC2+/+ organoid xenografts, indicating that the AML phenotype was maintained after engraftment (Fig. 5e).